There is necessary focus on women's health in some key areas, such as cardiovascular disease, breast cancer and osteoporosis. Yet, urinary incontinence, as related to pelvic organ prolapse, has as tremendous impact on quality of life and economics. Daily urinary incontinence affects up to 15% of women over the age of 45. The prevalence increases with age and peaks at 49-52 years. It actually ranks third behind stroke and Alzheimer's disease for effects on quality of life. Unfortunately, only 25% of women will actually discuss their incontinence with their physician. By the time voiding dysfunction raises its "ugly head," less than 50% are using absorbent pads, 40% are seeking out the location of toilets on outings and 30% are attempting voiding manipulation. These conditions can overcome their personal and professional lives, leading to depression in up to 60% of women.
From an economic perspective, the annual direct healthcare costs of urinary incontinence (treatment, care, hospital admissions, complications, diagnosis) are higher than equivalent costs of breast cancer, pneumonia and influenza combined. 50-75% is spent on resources for incontinence management, i.e., pads, protection and laundry.
We are committed to recognizing, diagnosing and managing the urological issues that affect a large portion of the female population.
Our urologists are nationally involved with advancing the quality of treatment and improving patients' quality of life as it relates to incontinence, prolapse and other complex female reconstructive issues. They are also specialists in different aspects of femal health: cancer, stone disease and other benign urological conditions.